EXACT Therapeutics AS (OSL:EXTX)

Norway flag Norway · Delayed Price · Currency is NOK
1.840
-0.030 (-1.60%)
At close: Mar 4, 2026
-45.24%
Market Cap 116.40M
Revenue (ttm) n/a
Net Income (ttm) -72.20M
Shares Out 63.26M
EPS (ttm) -1.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,648
Average Volume 11,555
Open 1.880
Previous Close 1.870
Day's Range 1.830 - 1.880
52-Week Range 1.150 - 3.860
Beta 0.23
RSI 53.11
Earnings Date Apr 8, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 12
Stock Exchange Oslo Børs
Ticker Symbol EXTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.